BSGM Valuation

BioSig Technologies Inc

Add to Watchlist

Advanced Chart

3.810

-0.21(-5.224%)1D

Overview
Forecast
Valuation
Earnings

BSGM Relative Valuation

BSGM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BSGM is overvalued; if below, it's undervalued.

Historical Valuation

BioSig Technologies Inc (BSGM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -10.61. The fair price of BioSig Technologies Inc (BSGM) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 3.76 USD , BioSig Technologies Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：3.76

Fair

Undervalued

-25.12

Trailing

Forward

0.00

EV/EBITDA

BioSig Technologies Inc. (BSGM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-27.68

EV/EBIT

BioSig Technologies Inc. (BSGM) has a current EV/EBIT of -27.68. The 5-year average EV/EBIT is -9.90. The thresholds are as follows: Strongly Undervalued below -39.13, Undervalued between -39.13 and -24.52, Fairly Valued between 4.72 and -24.52, Overvalued between 4.72 and 19.34, and Strongly Overvalued above 19.34. The current Forward EV/EBIT of -27.68 falls within the Undervalued range.

0.00

BioSig Technologies Inc. (BSGM) has a current PS of 0.00. The 5-year average PS is 95.25. The thresholds are as follows: Strongly Undervalued below -92.35, Undervalued between -92.35 and 1.45, Fairly Valued between 189.05 and 1.45, Overvalued between 189.05 and 282.84, and Strongly Overvalued above 282.84. The current Forward PS of 0.00 falls within the Undervalued range.

-194.88

P/OCF

BioSig Technologies Inc. (BSGM) has a current P/OCF of -194.88. The 5-year average P/OCF is -56.29. The thresholds are as follows: Strongly Undervalued below -265.92, Undervalued between -265.92 and -161.10, Fairly Valued between 48.53 and -161.10, Overvalued between 48.53 and 153.35, and Strongly Overvalued above 153.35. The current Forward P/OCF of -194.88 falls within the Undervalued range.

0.00

P/FCF

BioSig Technologies Inc. (BSGM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.03. The thresholds are as follows: Strongly Undervalued below -0.22, Undervalued between -0.22 and -0.09, Fairly Valued between 0.15 and -0.09, Overvalued between 0.15 and 0.28, and Strongly Overvalued above 0.28. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

BioSig Technologies Inc (BSGM) has a current Price-to-Book (P/B) ratio of 41.24. Compared to its 3-year average P/B ratio of -232.05 , the current P/B ratio is approximately -117.77% higher. Relative to its 5-year average P/B ratio of -232.05, the current P/B ratio is about -117.77% higher. BioSig Technologies Inc (BSGM) has a Forward Free Cash Flow (FCF) yield of approximately -3.45%. Compared to its 3-year average FCF yield of -37.49%, the current FCF yield is approximately -90.80% lower. Relative to its 5-year average FCF yield of -37.49% , the current FCF yield is about -90.80% lower.

37.42

P/B

Median3y

-232.05

Median5y

-232.05

-3.34

FCF Yield

Median3y

-37.49

Median5y

-37.49

Competitors Valuation Multiple

The average P/S ratio for BSGM's competitors is 0.99, providing a benchmark for relative valuation. BioSig Technologies Inc Corp (BSGM) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

BSGM.O

BioSig Technologies Inc

Anika Therapeutics Inc

Performance Decomposition

Market capitalization of BSGM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of BSGM in the past 1 year is driven by Unknown.